series-c-plus
Stage
1990
Founded
1
Investors
About
Crescendo Biologics is a clinical-stage immuno-oncology company developing novel T-cell enhancing therapeutics using its proprietary Humabody® platform. They focus on creating differentiated T-cell engager product candidates for solid tumors.
Explore Crescendo Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.